Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04347993 · ClinicalTrials.gov registry record
A Prospective "Universal" Observational Database for COVID-19
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 4,588
- Enrollment target
NCT04347993 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 4,588 participants.
The verdict
NCT04347993 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 4,588 participants
- Enrollment target
Study Summary
The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (HMH). HMH utilizes the EPIC system at most of the facilities, which will serve as the primary data source. The database will be designed within the REDCap system. A de-identified dataset will be sent to COTA for primary statistical analysis as requested by the research teams.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,588 participants |
| Start Date | 2020-03-27 |
| Est. Completion | 2023-06-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04347993
The ClinicalTrials.gov registry entry for NCT04347993 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 4,588 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04347993 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04347993 about?
NCT04347993 is a clinical study titled "A Prospective "Universal" Observational Database for COVID-19". The Hackensack Meridian Health Universal Observational COVID-19, a descriptive observational database, is a multi-center initiative collecting data throughout the Hackensack Meridian Health Network (HMH). HMH utilizes the EPIC system at most of the facilities, which will serve as the primary data so...
What is the current status of trial NCT04347993?
This trial is currently completed. The enrollment target is 4,588 participants. The study started on 2020-03-27. Estimated completion is 2023-06-12.
Who is sponsoring clinical trial NCT04347993?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.